000			02387 a2200685 4500
005			20250516185702.0
264		0	_c20140811
008			201408s 0 0 eng d
022			_a1569-8041
024	7		_a10.1093/annonc/mdt492 _2doi
040			_aNLM _beng _cNLM
100	1		_aHeng, D Y C
245	0	0	_aOutcomes of patients with metastatic renal cell carcinoma that do not meet eligibility criteria for clinical trials. _h[electronic resource]
260			_bAnnals of oncology : official journal of the European Society for Medical Oncology _cJan 2014
300			_a149-54 p. _bdigital
500			_aPublication Type: Journal Article
650	0	4	_aAntibodies, Monoclonal, Humanized _xadministration & dosage
650	0	4	_aAntineoplastic Combined Chemotherapy Protocols _xtherapeutic use
650	0	4	_aBevacizumab
650	0	4	_aBrain Neoplasms _xdrug therapy
650	0	4	_aCarcinoma, Renal Cell _xdrug therapy
650	0	4	_aClinical Trials as Topic
650	0	4	_aDisease-Free Survival
650	0	4	_aEligibility Determination
650	0	4	_aHumans
650	0	4	_aIndazoles
650	0	4	_aIndoles _xadministration & dosage
650	0	4	_aKaplan-Meier Estimate
650	0	4	_aKarnofsky Performance Status
650	0	4	_aKidney Neoplasms _xdrug therapy
650	0	4	_aMiddle Aged
650	0	4	_aMolecular Targeted Therapy
650	0	4	_aNiacinamide _xadministration & dosage
650	0	4	_aPhenylurea Compounds _xadministration & dosage
650	0	4	_aPyrimidines _xadministration & dosage
650	0	4	_aPyrroles _xadministration & dosage
650	0	4	_aSorafenib
650	0	4	_aSulfonamides _xadministration & dosage
650	0	4	_aSunitinib
650	0	4	_aTreatment Outcome
700	1		_aChoueiri, T K
700	1		_aRini, B I
700	1		_aLee, J
700	1		_aYuasa, T
700	1		_aPal, S K
700	1		_aSrinivas, S
700	1		_aBjarnason, G A
700	1		_aKnox, J J
700	1		_aMackenzie, M
700	1		_aVaishampayan, U N
700	1		_aTan, M H
700	1		_aRha, S Y
700	1		_aDonskov, F
700	1		_aAgarwal, N
700	1		_aKollmannsberger, C
700	1		_aNorth, S
700	1		_aWood, L A
773	0		_tAnnals of oncology : official journal of the European Society for Medical Oncology _gvol. 25 _gno. 1 _gp. 149-54
856	4	0	_uhttps://doi.org/10.1093/annonc/mdt492 _zAvailable from publisher's website
999			_c23384766 _d23384766